BioNTech (ADRs) Aktie
101,00
EUR
+4,85
EUR
+5,04
%
107,02
USD
+5,14
USD
+5,05
%
BioNTech (ADRs) Aktie Analyse
15.11.24 | BioNTech (ADRs) Neutral | JP Morgan Chase & Co. | |
05.11.24 | BioNTech (ADRs) Neutral | JP Morgan Chase & Co. | |
02.10.24 | BioNTech (ADRs) Neutral | UBS AG | |
18.09.24 | BioNTech (ADRs) Neutral | UBS AG | |
16.09.24 | BioNTech (ADRs) Neutral | JP Morgan Chase & Co. | |
13.09.24 | BioNTech (ADRs) Hold | Jefferies & Company Inc. | |
16.08.24 | BioNTech (ADRs) Hold | Jefferies & Company Inc. | |
06.08.24 | BioNTech (ADRs) Neutral | Goldman Sachs Group Inc. | |
Werbung
|
|||
05.08.24 | BioNTech (ADRs) Hold | Jefferies & Company Inc. | |
24.05.24 | BioNTech (ADRs) Hold | Deutsche Bank AG | |
10.05.24 | BioNTech (ADRs) Neutral | UBS AG | |
08.05.24 | BioNTech (ADRs) Hold | Deutsche Bank AG | |
07.05.24 | BioNTech (ADRs) Neutral | Goldman Sachs Group Inc. | |
06.05.24 | BioNTech (ADRs) Hold | Jefferies & Company Inc. | |
23.04.24 | BioNTech (ADRs) Hold | Deutsche Bank AG | |
22.03.24 | BioNTech (ADRs) Hold | Deutsche Bank AG | |
21.03.24 | BioNTech (ADRs) Hold | Deutsche Bank AG | |
21.03.24 | BioNTech (ADRs) Neutral | Goldman Sachs Group Inc. | |
20.03.24 | BioNTech (ADRs) Hold | Jefferies & Company Inc. | |
20.03.24 | BioNTech (ADRs) Neutral | UBS AG | |
09.01.24 | BioNTech (ADRs) Neutral | UBS AG | |
14.12.23 | BioNTech (ADRs) Neutral | UBS AG | |
12.12.23 | BioNTech (ADRs) Hold | Jefferies & Company Inc. | |
28.11.23 | BioNTech (ADRs) Neutral | UBS AG | |
08.11.23 | BioNTech (ADRs) Neutral | Goldman Sachs Group Inc. | |
07.11.23 | BioNTech (ADRs) Neutral | Goldman Sachs Group Inc. | |
30.10.23 | BioNTech (ADRs) Neutral | JP Morgan Chase & Co. | |
16.10.23 | BioNTech (ADRs) Neutral | UBS AG | |
06.09.23 | BioNTech (ADRs) Hold | Jefferies & Company Inc. | |
01.09.23 | BioNTech (ADRs) Hold | Jefferies & Company Inc. | |
18.08.23 | BioNTech (ADRs) Hold | Jefferies & Company Inc. | |
08.08.23 | BioNTech (ADRs) Hold | Deutsche Bank AG | |
07.08.23 | BioNTech (ADRs) Hold | Jefferies & Company Inc. | |
06.06.23 | BioNTech (ADRs) Neutral | UBS AG | |
05.06.23 | BioNTech (ADRs) Neutral | Goldman Sachs Group Inc. | |
18.05.23 | BioNTech (ADRs) Hold | Deutsche Bank AG | |
10.05.23 | BioNTech (ADRs) Equal-weight | Morgan Stanley | |
09.05.23 | BioNTech (ADRs) Neutral | Goldman Sachs Group Inc. | |
08.05.23 | BioNTech (ADRs) Hold | Jefferies & Company Inc. | |
26.04.23 | BioNTech (ADRs) Neutral | Goldman Sachs Group Inc. | |
24.04.23 | BioNTech (ADRs) Hold | Deutsche Bank AG | |
28.03.23 | BioNTech (ADRs) Neutral | Goldman Sachs Group Inc. | |
28.03.23 | BioNTech (ADRs) Hold | Jefferies & Company Inc. | |
01.02.23 | BioNTech (ADRs) Neutral | UBS AG | |
16.01.23 | BioNTech (ADRs) Neutral | Goldman Sachs Group Inc. | |
11.01.23 | BioNTech (ADRs) Neutral | JP Morgan Chase & Co. | |
21.11.22 | BioNTech (ADRs) Neutral | JP Morgan Chase & Co. | |
15.11.22 | BioNTech (ADRs) Neutral | UBS AG | |
08.11.22 | BioNTech (ADRs) Neutral | Goldman Sachs Group Inc. | |
24.10.22 | BioNTech (ADRs) Neutral | JP Morgan Chase & Co. |